Short-term and long-term effects of osteoporosis therapies
Crossref DOI link: https://doi.org/10.1038/nrendo.2015.71
Published Online: 2015-05-12
Published Print: 2015-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Reid, Ian R.
Text and Data Mining valid from 2015-05-12
Article History
First Online: 12 May 2015
Competing interests
: I.R.R. has received research grants or speaking and/or consulting fees from Amgen, Lilly, Merck, Novartis and Sanofi.